Streetbeat News

Stock Prices

ABT

Abbott Laboratories (NYSE:ABT) has seen a 21.31% increase in short interest, now at 12.70 million shares or 0.74% of float, taking 2.13 days on average to cover. This rise in short interest can indicate a bearish market sentiment towards ABT, though it has less short interest compared to its peers' average of 3.93%. The increase in shorting does not necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 6:30 pm

SCHW

Charles Schwab (NYSE:SCHW) has seen a decrease in short interest, with 17.98 million shares sold short, representing 1.08% of its float. This marks a 10.74% decline since the last report. The current short interest suggests a bullish sentiment among investors, as it is lower than the peer group average of 4.91%. Short interest is a key indicator of market sentiment, and a decrease often signals that investors are becoming more optimistic about a stock's future performance.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 6:30 pm

Verizon Communications (NYSE:VZ) has seen a 10.09% increase in its short percent of float since the last report, with 50.34 million shares sold short, representing 1.2% of available shares. This indicates a bearish market sentiment, although it's below the peer group average of 1.84% short interest. Short interest is a key indicator of market sentiment, and an increase suggests investors are expecting the price to fall. However, high short interest can also lead to bullish outcomes under certain conditions.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 6:30 pm

CMND

SPRC

SciSparc Ltd. (NASDAQ:SPRC) and Clearmind Medicine Inc. (NASDAQ:CMND) announced the submission of three international patent applications for novel proprietary combinations of psychedelic compounds, boosting their shares. This collaboration has led to 11 patent applications, aiming to strengthen their position in the psychedelic drug development market.

Portfolio Pulse from Erica Kollmann

February 20, 2024 | 6:29 pm

BABA

BIDU

EWH

FXI

NIO

NVDA

PDD

Chinese stocks in the U.S. market fell despite the People's Bank of China cutting the five-year prime loan rate by 25 basis points to 3.95% to support the real estate sector. The iShares China Large-Cap ETF and the iShares MSCI Hong Kong ETF saw declines, as did major Chinese companies like JD.com, Nio, Baidu, Alibaba, and PDD Holdings. The downturn was influenced by broader U.S. tech stock trends, with Nvidia experiencing a significant drop.

Portfolio Pulse from Piero Cingari

February 20, 2024 | 6:29 pm

TEVA

Teva Pharmaceutical Industries (NYSE:TEVA) CEO Richard Francis confirmed the company will not split into two entities, focusing on a unified approach to manage its generics and branded drugs businesses. Despite challenges, Teva remains optimistic, leveraging collaborations with Israeli universities for R&D. The company plans to divest its API business, valued at $1 billion, expecting significant interest. The divestiture is aimed to be completed in the first half of 2025, with TEVA shares currently up 0.88% at $13.14.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 6:24 pm

AGRI

DFS

EVA

FLR

MEDS

MNPR

VZIO

Fluor Corporation's shares fell by 7.7% following its Q4 results, with earnings beating estimates but sales missing expectations. Other stocks moved significantly in Tuesday's session, with notable gainers including TRxADE HEALTH, AgriFORCE Growing Systems, and Monopar Therapeutics, among others, due to various positive announcements. Losers included RAPT Therapeutics, MicroCloud Hologram, and Summit Therapeutics, primarily due to negative news or disappointing results.

Portfolio Pulse from Avi Kapoor

February 20, 2024 | 6:21 pm

DVA

FMS

Fresenius Medical Care AG (NYSE:FMS) reported Q4 2023 revenue of €4.9 billion, nearly matching consensus estimates and showing flat year-over-year growth. Adjusted EPS increased by 4% to €0.88, surpassing consensus. The company treated 332,548 patients in 3,925 clinics worldwide and proposed a 6% dividend increase. For 2024, it expects low- to mid-single-digit revenue growth and mid- to high-teens operating income growth. Fresenius forecasts 0.5%-2% patient volume growth, slightly lower than DaVita Inc's (NYSE:DVA) 1%-2% expectations. FMS shares dropped 2.96% to $20.49.

Portfolio Pulse from Vandana Singh

February 20, 2024 | 6:17 pm

ROKU

Recent analysis of options activity for Roku (NASDAQ:ROKU) reveals a bearish sentiment among investors, with 65% of trades being bearish and 34% bullish. The options trades have focused on a price range of $50.0 to $120.0 for Roku. Notable trades include a mix of bearish, bullish, and neutral sentiments with varying expiration dates and strike prices. Roku, a leading streaming platform, has seen a recent price drop of -5.5%, with its stock currently trading at $68.04. The company is anticipated to release its earnings in 64 days.

Portfolio Pulse from Benzinga Insights

February 20, 2024 | 6:15 pm

ARM

NVDA

SSNLF

Samsung Electronics Co (OTC:SSNLF) and Arm Holdings Plc (NASDAQ:ARM) have announced a collaboration to develop the next-generation Arm Cortex-X CPU using Samsung's Gate-All-Around process technology. This partnership aims to drive innovations in the semiconductor industry, focusing on a 2-nanometer AI chipset for mobile computing and data centers. Meanwhile, Nvidia Corp (NASDAQ:NVDA) increased its stake in Arm Holdings, which has seen its shares surge by 119% over the past quarter following its IPO.

Portfolio Pulse from Anusuya Lahiri

February 20, 2024 | 6:08 pm